Construction of Antibacterial N-Halamine Polymer Nanomaterials Capable of Bacterial Membrane Disruption for Efficient Anti-Infective Wound Therapy

Macromol Biosci. 2019 Apr;19(4):e1800453. doi: 10.1002/mabi.201800453. Epub 2019 Jan 15.

Abstract

The increasing occurrence of bacterial infection at the wound sites is a serious global problem, demanding the rapid development of new antibacterial materials for wound dressing to avoid the abuse of antibiotics and thereby antibiotic resistance. In this work, the authors first report on antibacterial N-halamine polymer nanomaterials based on a strategic copolymerization of 3-allyl-5,5-dimethylhydantoin (ADMH) and methyl methacrylate (MMA), which exhibits in vitro and in vivo antimicrobial efficacy against pathogenic bacteria including Staphylococcus aureus and Escherichia coli. Particularly, when a biological evaluation is run for wound therapy, the N-halamine polymer nanomaterials exhibit a powerful antibacterial efficiency and wound healing ability after a series of histological examination of mouse wound. After the evaluation of biological and chemical surroundings, the proposed four-stage mechanism suggests that, with unique antibacterial NCl bonds, the N-halamine polymer nanomaterials can disrupt the bacterial membrane, as a result causing intracellular content leaked out and thereby cell death. Based on the synergistic action of antibacterial and wound therapy, the N-halamine polymer nanomaterials are expected to be promising as wound dressing materials in medical healing and biomaterials.

Keywords: N-halamine polymer nanomaterials; antibacterial; antibacterial dressing; bacterial membrane disruption; wound therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amines* / chemistry
  • Amines* / pharmacology
  • Animals
  • Anti-Bacterial Agents* / chemistry
  • Anti-Bacterial Agents* / pharmacology
  • Bandages*
  • Cell Membrane / metabolism*
  • Escherichia coli / metabolism*
  • Escherichia coli Infections* / metabolism
  • Escherichia coli Infections* / microbiology
  • Escherichia coli Infections* / pathology
  • Escherichia coli Infections* / therapy
  • Mice
  • Nanostructures* / chemistry
  • Nanostructures* / therapeutic use
  • Polymethacrylic Acids* / chemistry
  • Polymethacrylic Acids* / pharmacology
  • Staphylococcal Infections* / metabolism
  • Staphylococcal Infections* / microbiology
  • Staphylococcal Infections* / pathology
  • Staphylococcal Infections* / therapy
  • Staphylococcus aureus / metabolism*
  • Wound Infection* / metabolism
  • Wound Infection* / microbiology
  • Wound Infection* / pathology
  • Wound Infection* / therapy
  • Wounds and Injuries / metabolism
  • Wounds and Injuries / microbiology
  • Wounds and Injuries / pathology
  • Wounds and Injuries / therapy

Substances

  • Amines
  • Anti-Bacterial Agents
  • N-halamine
  • Polymethacrylic Acids